Robert G. Trapp

Ocrelizumab, a humanized anti‐CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo‐controlled, dose‐ranging study

Mark C. Genovese, Jeffrey Kaine, Mitchell B. Lowenstein et al. · Arthritis & Rheumatism · 2008 · 205 citations

Medicine, Pharmacology, Pharmacotherapy +16

Denosumab‐mediated increase in hand bone mineral density associated with decreased progression of bone erosion in rheumatoid arthritis patients

Atul Deodhar, Robin K. Dore, David R. Mandel et al. · Arthritis Care & Research · 2010 · 122 citations

Medicine, Clinical Sciences, Internal Medicine +17

Safety, Tolerability, and Clinical Outcomes after Intraarticular Injection of a Recombinant Adeno-associated Vector Containing a Tumor Necrosis Factor Antagonist Gene: Results of a Phase 1/2 Study

Philip J. Mease, Nathan Wei, Edward J. Fudman et al. · The Journal of Rheumatology · 2009 · 112 citations · Full text

Medicine, Clinical Sciences, Immunology +17

C4 binding protein deficiency in a patient with atypical Behçet's disease.

Robert G. Trapp, Mark P. Fletcher, J Forristal et al. · PubMed · 1987 · 38 citations

Life Sciences, Immunology, Pathology +17

Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee

A. Weaver, Bernard Rubin, Jacques Caldwell et al. · Clinical Therapeutics · 1995 · 27 citations

Medicine, Pharmacology, Pharmacotherapy +6